FI874082A0 - Menetelmä glykopeptidiantibioottien valmistamiseksi ja niitä tuottavia mikro-organismiviljelmiä - Google Patents

Menetelmä glykopeptidiantibioottien valmistamiseksi ja niitä tuottavia mikro-organismiviljelmiä

Info

Publication number
FI874082A0
FI874082A0 FI874082A FI874082A FI874082A0 FI 874082 A0 FI874082 A0 FI 874082A0 FI 874082 A FI874082 A FI 874082A FI 874082 A FI874082 A FI 874082A FI 874082 A0 FI874082 A0 FI 874082A0
Authority
FI
Finland
Prior art keywords
cultures
glycopeptide antibiotics
microorganisms producing
preparing glycopeptide
preparing
Prior art date
Application number
FI874082A
Other languages
English (en)
Swedish (sv)
Other versions
FI90993C (fi
FI90993B (fi
FI874082A (fi
Inventor
Robert L Hamill
James Albert Mabe
David Francis Mahoney
Walter Mitsuo Nakatsukasa
Raymond Che-Fong Yao
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of FI874082A0 publication Critical patent/FI874082A0/fi
Publication of FI874082A publication Critical patent/FI874082A/fi
Application granted granted Critical
Publication of FI90993B publication Critical patent/FI90993B/fi
Publication of FI90993C publication Critical patent/FI90993C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/365—Nocardia
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/872—Nocardia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI874082A 1986-09-19 1987-09-18 Menetelmä glykopeptidiantibioottien valmistamiseksi ja niitä tuottavia mikro-organismiviljelmiä FI90993C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90979186A 1986-09-19 1986-09-19
US90979186 1986-09-19

Publications (4)

Publication Number Publication Date
FI874082A0 true FI874082A0 (fi) 1987-09-18
FI874082A FI874082A (fi) 1988-03-20
FI90993B FI90993B (fi) 1994-01-14
FI90993C FI90993C (fi) 1994-04-25

Family

ID=25427837

Family Applications (1)

Application Number Title Priority Date Filing Date
FI874082A FI90993C (fi) 1986-09-19 1987-09-18 Menetelmä glykopeptidiantibioottien valmistamiseksi ja niitä tuottavia mikro-organismiviljelmiä

Country Status (23)

Country Link
US (2) US5312738A (fi)
EP (1) EP0265071B1 (fi)
JP (2) JP2634174B2 (fi)
KR (1) KR960013093B1 (fi)
CN (1) CN1061095C (fi)
AU (1) AU608534B2 (fi)
CA (1) CA1339033C (fi)
CY (1) CY1691A (fi)
DE (1) DE3782720T2 (fi)
DK (1) DK167689B1 (fi)
EG (1) EG18377A (fi)
ES (1) ES2052574T3 (fi)
FI (1) FI90993C (fi)
GR (1) GR3006311T3 (fi)
HK (1) HK44393A (fi)
HU (1) HU198964B (fi)
IE (1) IE60132B1 (fi)
MX (1) MX168708B (fi)
NZ (1) NZ221856A (fi)
PH (1) PH24288A (fi)
PT (1) PT85742B (fi)
SU (1) SU1724015A3 (fi)
ZA (1) ZA877003B (fi)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946941A (en) * 1986-01-24 1990-08-07 Shionogi & Co., Ltd. Novel glycopeptide antibiotics
EG18377A (en) * 1986-09-19 1993-04-30 Lilly Co Eli Process for preparing glycopeptide antibiotics
US5071749A (en) * 1987-04-16 1991-12-10 Shionogi & Co., Ltd. Glycopetide antibiotic pa-45052-b
EP0309161A3 (en) * 1987-09-19 1990-12-27 Beecham Group Plc Antibiotic compounds
US5534420A (en) * 1988-07-28 1996-07-09 Eli Lilly And Company Biotransformation of glycopeptide antibiotics
CA1339808C (en) * 1988-10-19 1998-04-07 Manuel Debono Glycopeptide antibiotics
JP2577133B2 (ja) * 1989-11-27 1997-01-29 スティフティング フォール ド テフニスヘ ウェッテンスハッペン 船舶のプロペラ
IL96603A (en) * 1989-12-13 1998-02-08 Lilly Co Eli Antibacterial glycopeptide derivativesProcess for their preparation and pharmaceutical preparations containing the same
US5187082A (en) * 1990-08-16 1993-02-16 Eli Lilly And Company Process for producing A83850 antibiotics
RU2145609C1 (ru) * 1994-01-28 2000-02-20 Эли Лилли Энд Компани Производные гликопептида или их соли, способ получения, фармацевтическая композиция
US5840684A (en) * 1994-01-28 1998-11-24 Eli Lilly And Company Glycopeptide antibiotic derivatives
US5919756A (en) * 1996-06-28 1999-07-06 Eli Lilly And Company Amides
US5952466A (en) * 1997-11-12 1999-09-14 Eli Lilly And Company Reductive alkylation of glycopeptide antibiotics
US5952310A (en) * 1997-05-20 1999-09-14 Eli Lilly And Company Glycopeptide hexapeptides
JP4307723B2 (ja) 1998-05-01 2009-08-05 イーライ リリー アンド カンパニー Ｎ１−修飾グリコペプチド
WO2001036655A2 (en) * 1999-11-12 2001-05-25 Eli Lilly And Company Method for optimization of a medium for glycopeptide fermentation
US7019129B1 (en) * 2000-05-09 2006-03-28 Biosearch Technologies, Inc. Dark quenchers for donor-acceptor energy transfer
US6734165B2 (en) * 2001-08-23 2004-05-11 The Trustees Of Columbia University In The City Of New York Method for re-sensitizing vancomycin resistant bacteria which selectively cleave a cell wall depsipeptide
US6551591B1 (en) 2001-09-07 2003-04-22 Essential Therapeutics, Inc. Antibiotics from microbispora
US20050289488A1 (en) * 2004-06-29 2005-12-29 I-Ju Chou System and method for mask defect detection
WO2006010038A2 (en) * 2004-07-08 2006-01-26 Biosearch Technologies, Inc. Inducible fluorescence assay
EP2096107A1 (en) 2004-12-23 2009-09-02 GPC Biotech AG Derivatives of squaric acid with anti-proliferative activity
CN101245068A (zh) 2007-02-14 2008-08-20 浙江医药股份有限公司新昌制药厂 结晶型态的恩替卡韦及其制备方法和其药物组合物及用途
US8450348B2 (en) * 2007-02-21 2013-05-28 Forma Tm, Llc Derivatives of squaric acid with anti-proliferative activity
CN101284799B (zh) 2007-03-23 2013-04-03 浙江医药股份有限公司新昌制药厂 咖啡酰奎宁酸含氮衍生物及其制备方法和其药物组合物及用途
EP2019101A1 (en) * 2007-07-26 2009-01-28 GPC Biotech AG Pyrazol[3,4-d]pyrimidin-4-one useful as Kinase Inhibitor
CN101397333A (zh) 2007-09-27 2009-04-01 浙江医药股份有限公司新昌制药厂 去羟基万古霉素及其制备方法、和其药物组合物及其用途
CN101545000B8 (zh) * 2008-03-28 2018-09-21 上海来益生物药物研究开发中心有限责任公司 一种提高东方拟无枝酸菌发酵生产eco-0501的产量的方法
EP2268608A4 (en) * 2008-04-01 2012-01-11 Biosearch Technologies Inc DARK NUCLEIC ACID STABILIZED FLUOROPHORE DEACTIVATOR PROBES
EP2112152A1 (en) 2008-04-22 2009-10-28 GPC Biotech AG Dihydropteridinones as Plk Inhibitors
EP2112150B1 (en) 2008-04-22 2013-10-16 Forma Therapeutics, Inc. Improved raf inhibitors
CN101828693B (zh) 2009-03-09 2013-01-02 浙江医药股份有限公司新昌制药厂 制备低粘度高流动性类胡萝卜素油悬浮液的方法及其应用
CN101928331B (zh) * 2009-06-26 2014-05-28 上海来益生物药物研究开发中心有限责任公司 一种化合物及其应用
EP2325185A1 (en) 2009-10-28 2011-05-25 GPC Biotech AG Plk inhibitor
CN102690330B (zh) * 2011-03-23 2014-10-08 浙江医药股份有限公司新昌制药厂 三取代糖肽类衍生物及药物组合物、以及其制备方法和用途
CN102690332B (zh) * 2011-03-23 2017-06-27 浙江医药股份有限公司新昌制药厂 新型糖肽类抗生素衍生物及药物组合物、以及其制备方法和用途
RU2011122942A (ru) 2011-06-08 2012-12-20 Общество С Ограниченной Ответственностью "Асинэкс Медхим" Новые ингибиторы киназ
JP5996187B2 (ja) * 2011-12-20 2016-09-21 株式会社ダイセル エクオールの製造方法
WO2014160250A2 (en) * 2013-03-13 2014-10-02 Yale University Site-selective functionalization of glycopeptide antibiotics
CN104805161A (zh) * 2014-01-29 2015-07-29 上海医药工业研究院 生产奥利万星前体a82846b的方法及培养基
JP6712991B2 (ja) 2014-07-17 2020-06-24 ザ メディシンズ カンパニー 高純度のオリタバンシン及びその製造方法
CN106190854B (zh) * 2015-04-29 2019-09-27 浙江海正药业股份有限公司 一种荒漠拟孢囊菌和奥利万星中间体的制备方法
CN106467570B (zh) * 2015-08-14 2020-04-07 正大天晴药业集团股份有限公司 糖肽类抗生素的还原烷基化方法
CN107619433B (zh) * 2016-07-15 2023-03-17 上海来益生物药物研究开发中心有限责任公司 糖肽类衍生物及其药学可接受的盐、制备方法和应用
CN106928323B (zh) * 2017-03-02 2021-08-20 重庆乾泰生物医药有限公司 一种高纯度奥利万星关键中间体a82846b的制备方法
CN108929860B (zh) * 2017-05-23 2023-08-22 上海来益生物药物研究开发中心有限责任公司 一种产chloroeremomycin的基因工程菌及其制备方法和应用
CN109929895B (zh) * 2019-04-02 2021-05-18 博瑞生物医药泰兴市有限公司 一种酸降解液
CN109971809B (zh) * 2019-04-02 2023-04-28 博瑞生物医药（苏州）股份有限公司 一种糖肽类抗生素中间体的发酵制备方法
CN113563426B (zh) * 2021-08-05 2023-03-31 丽珠集团福州福兴医药有限公司 奥利万星母核a82846b的分离纯化方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3067099A (en) * 1955-09-16 1962-12-04 Lilly Co Eli Vancomycin and method for its preparation
US4558008A (en) * 1983-12-13 1985-12-10 Eli Lilly And Company Process for production of A-51568B antibiotic
US4547488A (en) * 1984-04-16 1985-10-15 Eli Lilly And Company Antibiotic M43D, pharmaceutical compositions and method of use
US4548924A (en) * 1984-04-16 1985-10-22 Eli Lilly And Company Antibiotics M43B and M43C, pharmaceutical composition and method of use
US4548925A (en) * 1984-04-16 1985-10-22 Eli Lilly And Company Antibiotic M43A, pharmaceutical composition and method of use
US4946941A (en) * 1986-01-24 1990-08-07 Shionogi & Co., Ltd. Novel glycopeptide antibiotics
GB8618445D0 (en) * 1986-07-29 1986-09-03 Lepetit Spa Antibiotic a 42867
DK387287A (da) * 1986-07-30 1988-01-31 Smithkline Beckman Corp Glycopeptidantibiotika
EG18377A (en) * 1986-09-19 1993-04-30 Lilly Co Eli Process for preparing glycopeptide antibiotics
US5071749A (en) * 1987-04-16 1991-12-10 Shionogi & Co., Ltd. Glycopetide antibiotic pa-45052-b

Also Published As

Publication number Publication date
IE872529L (en) 1988-03-19
HK44393A (en) 1993-05-14
PH24288A (en) 1990-05-29
ZA877003B (en) 1989-04-26
EG18377A (en) 1993-04-30
PT85742B (pt) 1990-06-29
FI90993C (fi) 1994-04-25
GR3006311T3 (fi) 1993-06-21
JP2634174B2 (ja) 1997-07-23
EP0265071B1 (en) 1992-11-19
DK489787A (da) 1988-03-21
AU608534B2 (en) 1991-04-11
SU1724015A3 (ru) 1992-03-30
MX168708B (es) 1993-06-04
DE3782720T2 (de) 1993-04-22
DE3782720D1 (de) 1992-12-24
CY1691A (en) 1994-01-14
US5843437A (en) 1998-12-01
DK167689B1 (da) 1993-12-06
ES2052574T3 (es) 1994-07-16
KR960013093B1 (ko) 1996-09-30
EP0265071A1 (en) 1988-04-27
HU198964B (en) 1989-12-28
IE60132B1 (en) 1994-06-01
FI90993B (fi) 1994-01-14
HUT46365A (en) 1988-10-28
CN87106483A (zh) 1988-06-08
CN1061095C (zh) 2001-01-24
KR880004097A (ko) 1988-06-01
JPH09182581A (ja) 1997-07-15
JPS6393798A (ja) 1988-04-25
JP2806912B2 (ja) 1998-09-30
DK489787D0 (da) 1987-09-17
PT85742A (en) 1987-10-01
CA1339033C (en) 1997-04-01
AU7865887A (en) 1988-03-24
FI874082A (fi) 1988-03-20
NZ221856A (en) 1991-12-23
US5312738A (en) 1994-05-17

Similar Documents

Publication Publication Date Title
FI874082A0 (fi) Menetelmä glykopeptidiantibioottien valmistamiseksi ja niitä tuottavia mikro-organismiviljelmiä
EG18797A (en) Process for production of b avermectins and cultures thereof
BG60053B2 (en) Method for preparing of antibiotics
AU7873187A (en) Method of culturing leukocytes
AU7346087A (en) Bioreactor for cultivation of microorganisms
AR241936A1 (es) Procedimiento para aumentar la actividad de la enzima nitrilo-hidratasa por unidad de fluido de cultivo de bacterias de la especie rhodococcus rhodochrous.
AR244344A1 (es) Un procedimiento para la produccion de una avermectina.
EP0231111A3 (en) Glycopeptide antibiotics, their preparation and use and microorganisms for producing them
GB8800797D0 (en) Method of preparing immobilized enzyme/immobilized microbe
GB8700354D0 (en) Culture of micro-organisms
CS572487A2 (en) Method of antibiotic production
IL82119A0 (en) Antibiotic a42125 and process for its production
AU1050388A (en) Material and method for promoting growth of anaerobic bacteria
IL81751A0 (en) Fermentation of bacteria at high productivities
GB2210765B (en) Method of plant culture
ZA873894B (en) Fermentation method for producing polyether antibiotics
IT1217825B (it) Procedimento ed impianto per la coltura di microorganismi
CS754387A1 (en) Biotechnical method of invertase production
AU603416C (en) Process for production of B avermectins and cultures therefor
HUT46076A (en) Microbiological process for producing antibiotics of streptogramin type and fodder additives comprising the same
AU603415C (en) Process for production of avermectins and cultures therefor
RO88056B1 (ro) Procedeu de stimulare a dezvoltarii culturilor de actinomicete, producatoare de substante biologic active
HUT45276A (en) Process for production of oligomicin-komplex and its components by means of fermentation
CS160987A1 (en) Process for the inactivation and utilization of waste mycelium after preparing betalactamic antibiotics
TH6648EX (th) วิธีการเตรียมชิ้นกล้าสำหรับการเลี้ยงเนื้อเยื่อพืช

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: ELI LILLY AND COMPANY

MA Patent expired